'Hexaplex' vaccine aims to boost flu protection
Date | 26th, Feb 2024 |
---|---|
Source | ScienceDaily - General News Websites |
DESCRIPTION
A research team has developed a recombinant protein flu vaccine candidate. It utilizes a nanoliposome vaccine platform that underwent phase 2 and phase 3 clinical trials in South Korea and the Philippines as a COVID-19 vaccine candidate.